Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
112.39
+0.50 (0.45%)
At close: Apr 3, 2025, 4:00 PM
111.31
-1.08 (-0.96%)
Pre-market: Apr 4, 2025, 9:25 AM EDT
Gilead Sciences Stock Forecast
Stock Price Forecast
The 25 analysts with 12-month price forecasts for Gilead Sciences stock have an average target of 105.32, with a low estimate of 69 and a high estimate of 140. The average target predicts a decrease of -6.29% from the current stock price of 112.39.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Gilead Sciences stock from 27 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 3 | 3 | 4 | 4 |
Buy | 8 | 10 | 11 | 12 | 12 | 12 |
Hold | 10 | 12 | 12 | 11 | 11 | 11 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 20 | 24 | 26 | 26 | 27 | 27 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JP Morgan | JP Morgan | Buy Maintains $120 → $130 | Buy | Maintains | $120 → $130 | +15.67% | Mar 27, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $123 → $130 | Buy | Maintains | $123 → $130 | +15.67% | Mar 11, 2025 |
B of A Securities | B of A Securities | Strong Buy Maintains $116 → $126 | Strong Buy | Maintains | $116 → $126 | +12.11% | Mar 5, 2025 |
Wells Fargo | Wells Fargo | Buy Maintains $120 → $140 | Buy | Maintains | $120 → $140 | +24.57% | Mar 5, 2025 |
Oppenheimer | Oppenheimer | Buy Maintains $115 → $132 | Buy | Maintains | $115 → $132 | +17.45% | Mar 4, 2025 |
Financial Forecast
Revenue This Year
29.27B
from 28.75B
Increased by 1.81%
Revenue Next Year
30.42B
from 29.27B
Increased by 3.90%
EPS This Year
8.11
from 0.38
Increased by 2,034.79%
EPS Next Year
8.57
from 8.11
Increased by 5.63%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 30.3B | 32.8B | 35.1B | ||
Avg | 29.3B | 30.4B | 31.9B | ||
Low | 27.9B | 28.4B | 28.7B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 5.5% | 12.0% | 15.3% | ||
Avg | 1.8% | 3.9% | 4.8% | ||
Low | -2.8% | -3.1% | -5.5% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 8.56 | 9.53 | 10.86 | ||
Avg | 8.11 | 8.57 | 9.08 | ||
Low | 7.60 | 6.34 | 6.89 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 2,152.0% | 17.5% | 26.7% | ||
Avg | 2,034.8% | 5.6% | 5.9% | ||
Low | 1,901.3% | -21.8% | -19.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.